Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,700 | 29,800 | 34,200 | 39,000 | 35,500 |
| Receivables | 124,400 | 124,900 | 108,400 | 113,200 | 114,400 |
| Inventories | 125,600 | 116,300 | 111,800 | 84,400 | 89,400 |
| Income taxes - deferred | 28,400 | 29,200 | 27,600 | 22,900 | 25,400 |
| Other current assets | 0 | 0 | 3,400 | 0 | 0 |
| TOTAL | $388,200 | $351,100 | $320,200 | $297,300 | $311,700 |
| Non-Current Assets | |||||
| PPE Net | 205,800 | 205,100 | 209,400 | 180,100 | 178,000 |
| Investments And Advances | 21,500 | 23,200 | 23,500 | 20,800 | 90,400 |
| Intangibles | 418,700 | 403,300 | 398,800 | 396,300 | 397,000 |
| Other Non-Current Assets | 45,500 | 53,200 | 52,500 | 23,900 | 6,200 |
| TOTAL | $691,500 | $684,800 | $684,200 | $621,100 | $671,600 |
| Total Assets | $1,079,700 | $1,035,900 | $1,004,400 | $918,400 | $983,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 600 |
| Accounts payable and accrued liabilities | 186,100 | 189,600 | 177,300 | 175,000 | 185,500 |
| TOTAL | $186,100 | $189,600 | $177,300 | $175,000 | $186,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 307,300 | 276,900 | 245,500 | 279,900 | 296,900 |
| Other Non-Current Liabilities | 27,300 | 26,400 | 42,200 | 4,700 | 20,700 |
| TOTAL | $334,600 | $303,300 | $287,700 | $284,600 | $317,600 |
| Total Liabilities | $520,700 | $492,900 | $465,000 | $459,600 | $503,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 743,103 | 731,320 | 722,703 | 720,682 | 718,049 |
| Common Shares | 61,800 | 60,400 | 60,200 | 60,000 | 59,800 |
| Retained earnings | 179,000 | 157,900 | 143,400 | 121,700 | 139,100 |
| Other shareholders' equity | -48,600 | -51,300 | -44,200 | 8,000 | 6,800 |
| TOTAL | $559,000 | $543,000 | $539,400 | $458,800 | $479,600 |
| Total Liabilities And Equity | $1,079,700 | $1,035,900 | $1,004,400 | $918,400 | $983,300 |